Timing of Clinical Improvement and Symptom Resolution in the Treatment of Major Depressive Disorder

Publisher： Karger

E-ISSN： 1423-0224|56|2-3|132-137

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.56, Iss.2-3, 2008-02, pp. : 132-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Escitalopram in the Long-Term Treatment of Major Depressive Disorder in Elderly Patients

By  

Neuropsychobiology, Vol. 54, Iss. 3, 2007-03 ,pp. : 152-159

Karger

Access to resources Recommend Favorite

Psychomotor Changes in Major Depressive Disorder during Sertraline Treatment

By  

Neuropsychobiology, Vol. 59, Iss. 1, 2009-03 ,pp. : 34-42

Karger

Access to resources Recommend Favorite

Association between Serotonin Transporter-Linked Polymorphic Region and Escitalopram Antidepressant Treatment Response in Korean Patients with Major Depressive Disorder

By  

Neuropsychobiology, Vol. 66, Iss. 4, 2012-10 ,pp. : 221-229

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Oral Escitalopram as Continuation Treatment of Intravenous Citalopram in Patients with Major Depressive Disorder

By  

Neuropsychobiology, Vol. 54, Iss. 4, 2007-04 ,pp. : 201-207

Karger

Access to resources Recommend Favorite

Serum Ghrelin Levels and the Effects of Antidepressants in Major Depressive Disorder and Panic Disorder

By  

Neuropsychobiology, Vol. 66, Iss. 3, 2012-08 ,pp. : 185-192

Karger

Access to resources Recommend Favorite